Former President Donald Trump announced that he has no plans to sell his majority stake in his social media company, Truth Social, and intends to continue using the platform.
“No, I’m not selling,” Trump said on Friday when asked by Reuters. “I’m not leaving. I love it. I think it’s great.”
Following his statement, shares of Trump Media & Technology Group (TMTG), the company behind Truth Social, surged by 30 percent before closing up 12 percent higher than before the announcement. Trump holds about 57 percent ownership in TMTG, a company that saw its valuation skyrocket to nearly $10 billion when it was first listed on the stock market in March.
However, the company has lost significant value in recent months, with its stocks starting to decline since the Democratic Party announced that Biden would be stepping down and Vice President Kamala Harris would be the party’s nominee for president. Investor speculation suggests that the company’s performance is linked to Trump’s re-election chances, particularly as the 2024 election polls tighten. […]
— Read More: thepostmillennial.com
What Would You Do If Pharmacies Couldn’t Provide You With Crucial Medications or Antibiotics?
The medication supply chain from China and India is more fragile than ever since Covid. The US is not equipped to handle our pharmaceutical needs. We’ve already seen shortages with antibiotics and other medications in recent months and pharmaceutical challenges are becoming more frequent today.
Our partners at Jase Medical offer a simple solution for Americans to be prepared in case things go south. Their “Jase Case” gives Americans emergency antibiotics they can store away while their “Jase Daily” offers a wide array of prescription drugs to treat the ailments most common to Americans.
They do this through a process that embraces medical freedom. Their secure online form allows board-certified physicians to prescribe the needed drugs. They are then delivered directly to the customer from their pharmacy network. The physicians are available to answer treatment related questions.
